TP53 Mutation: Molecular Oncology Tumor Boards

This free case-based activity includes a crowd-sourced discussion of a 79-year-old male with an incidental finding of leukocytosis with lymphocytosis prior to elective knee replacement surgery in June of 2011. Originally posted on a forum in the ASCO Connection, users now have the opportunity to claim CME, completion, or participation certificates for completing this activity.

Learning Objectives:

  1. Analyze treatment options for patients with chronic lymphocytic leukemia
  2. Apply optimal treatment in patients with 17p13 deletion and TP53 mutation
  3. Review the laboratory studies that are used to predict the prognosis of chronic lymphocytic leukemia patients at diagnosis
  4. Discuss the role of targeted DNA sequence analysis in the evaluation and treatment of chronic lymphocytic leukemia patients

This activity was made available on 4/30/2015 and will be reviewed on an annual basis to determine continued availability. A maximum of 1 AMA PRA Category 1 Credit(s) ™ credit is available.

Competencies Addressed

Medical Knowledge (ACGME, AAPA)
Health Promotion, Health Protection, Disease Prevention, and Treatment (ONS)